Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Adiponectin regulates albuminuria and podocyte function in mice.

Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ.

J Clin Invest. 2008 May;118(5):1645-56. doi: 10.1172/JCI32691.

2.

Prevalence of chronic kidney disease in the United States.

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS.

JAMA. 2007 Nov 7;298(17):2038-47.

PMID:
17986697
3.

Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes.

Yano Y, Hoshide S, Ishikawa J, Hashimoto T, Eguchi K, Shimada K, Kario K.

J Clin Hypertens (Greenwich). 2007 Oct;9(10):775-82.

4.

Rosiglitazone decreases albuminuria in type 2 diabetic patients.

Miyazaki Y, Cersosimo E, Triplitt C, DeFronzo RA.

Kidney Int. 2007 Dec;72(11):1367-73. Epub 2007 Sep 5.

5.

Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.

Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, Ito T, Funahashi T.

Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1910-7. Epub 2007 Jul 12.

6.

Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo.

Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, Chan L, Goldstein BJ, Scalia R.

J Clin Invest. 2007 Jun;117(6):1718-26.

7.

The epidemiology of obesity.

Ogden CL, Yanovski SZ, Carroll MD, Flegal KM.

Gastroenterology. 2007 May;132(6):2087-102. Review.

PMID:
17498505
8.

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.

Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, Ito Y, Kamon J, Tsuchida A, Kumagai K, Kozono H, Hada Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Awazawa M, Takamoto I, Froguel P, Hara K, Tobe K, Nagai R, Ueki K, Kadowaki T.

Nat Med. 2007 Mar;13(3):332-9. Epub 2007 Feb 1.

PMID:
17268472
9.

A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.

Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS.

Am J Physiol Renal Physiol. 2007 Feb;292(2):F617-27. Epub 2006 Oct 3.

10.

Effect of adiponectin on murine colitis induced by dextran sulfate sodium.

Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S, Funahashi T, Shimomura I.

Gastroenterology. 2006 Sep;131(3):853-61.

PMID:
16952554
11.

Microalbuminuria as an early marker for cardiovascular disease.

de Zeeuw D, Parving HH, Henning RH.

J Am Soc Nephrol. 2006 Aug;17(8):2100-5. Epub 2006 Jul 6.

12.

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K.

J Clin Invest. 2006 Jul;116(7):1784-92. Review.

13.

Renal manifestations in the metabolic syndrome.

Locatelli F, Pozzoni P, Del Vecchio L.

J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S81-5. Review.

14.

Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists.

Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE.

J Biol Chem. 2006 Feb 3;281(5):2654-60. Epub 2005 Dec 2.

15.

Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.

Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D.

Am J Kidney Dis. 2005 Oct;46(4):587-94.

PMID:
16183412
16.
17.

Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes.

Looker HC, Krakoff J, Funahashi T, Matsuzawa Y, Tanaka S, Nelson RG, Knowler WC, Lindsay RS, Hanson RL.

J Clin Endocrinol Metab. 2004 Aug;89(8):4010-7.

PMID:
15292342
18.

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.

Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE.

J Biol Chem. 2004 Mar 26;279(13):12152-62. Epub 2003 Dec 29.

19.

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.

Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P.

Ann Intern Med. 2003 Dec 2;139(11):901-6.

PMID:
14644892
20.

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.

Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ.

J Clin Invest. 2003 Jul;112(1):91-100.

Supplemental Content

Support Center